Evidence map›Paper›PMID 27301489›Full record

Trial reportTrials2016

An organisational change intervention for increasing the delivery of smoking cessation support in addiction treatment centres: study protocol for a randomized controlled trial.

Billie Bonevski, Ashleigh Guillaumier, Anthony Shakeshaft, Michael Farrell, Flora Tzelepis, Scott Walsberger, Catherine D'Este, Chris Paul, Adrian Dunlop, Andrew Searles and 5 more

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Trials, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. System change interventions for smoking cessation.The Cochrane database of systematic reviews · 2017
    Pooled it
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 1 country.

Billie BonevskiSchool of Medicine & Public Health, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia. billie.bonevski@newcastle.edu.au.
Ashleigh GuillaumierSchool of Medicine & Public Health, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia.
Anthony ShakeshaftNational Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia.
Michael FarrellNational Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia.
Flora TzelepisSchool of Medicine & Public Health, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia.
Scott WalsbergerTobacco Control Unit, Cancer Council New South Wales, Woolloomooloo, NSW, Australia.
Catherine D'EsteNational Centre for Epidemiology & Population Health, Australian National University, Canberra, ACT, Australia.
Chris PaulSchool of Medicine & Public Health, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia.
Adrian DunlopDrug and Alcohol Clinical Services, Hunter New England Local Health District, Newcastle, NSW, Australia.
Andrew SearlesHunter Medical Research Institute, New Lambton, NSW, Australia.
Peter KellySchool of Psychology, University of Wollongong, Wollongong, NSW, Australia.
Rae FryTobacco Control Unit, Cancer Council New South Wales, Woolloomooloo, NSW, Australia.
Robert StirlingNetwork of Alcohol and other Drug Agencies, Sydney, NSW, Australia.
Carrie FowlieAlcohol, Tobacco and Other Drug Association ACT, Canberra, ACT, Australia.
Eliza SkeltonSchool of Medicine & Public Health, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia.
University of Newcastle Australia · AUAlcohol and Drug Foundation · AUCancer Council NSW · AUUNSW Sydney · AUAustralian National University · AUHunter Medical Research Institute · AUHunter New England Local Health District · AUUniversity of Wollongong · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe provision of smoking cessation support in Australian drug and alcohol treatment services is sub-optimal. This study examines the cost-effectiveness of an organisational change intervention to reduce smoking amongst clients attending drug and alcohol treatment services. METHODS/

designA cluster-randomised controlled trial will be conducted with drug and alcohol treatment centres as the unit of randomisation. Biochemically verified (carbon monoxide by breath analysis) client 7-day-point prevalence of smoking cessation at 6 weeks will be the primary outcome measure. The study will be conducted in 33 drug and alcohol treatment services in four mainland states and territories of Australia: New South Wales, Australian Capital Territory, Queensland, and South Australia. Eligible services are those with ongoing client contact and that include pharmacotherapy services, withdrawal management services, residential rehabilitation, counselling services, and case management services. Eligible clients are those aged over 16 years who are attending their first of a number of expected visits, are self-reported current smokers, proficient in the English language, and do not have severe untreated mental illness as identified by the service staff. Control services will continue to provide usual care to the clients. Intervention group services will receive an organisational change intervention, including assistance in developing smoke-free policies, nomination of champions, staff training and educational client and service resources, and free nicotine replacement therapy in order to integrate smoking cessation support as part of usual client care. DISCUSSION: If effective, the organisational change intervention has clear potential for implementation as part of the standard care in drug and alcohol treatment centres.

trial registrationAustralian and New Zealand Clinical Trials Registry, ACTRN12615000204549 . Registered on 3 March 2015.

Indexed as

AustraliaClinical ProtocolsCost-Benefit AnalysisDelivery of Health Care, IntegratedDrug UsersHealth Care CostsHumansOrganizational InnovationResearch DesignSmokersSmokingSmoking CessationSubstance Abuse Treatment CentersSubstance-Related DisordersTime FactorsTreatment OutcomeAddictionOrganisational changeSmoking

Identifiers

PMID27301489
PMCPMC4907075
OpenAlexW2427074704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.